LLS (Leukemia & Lymphoma Society) Sustainability Profile
The Leukemia & Lymphoma Society (LLS), headquartered in the United States, is a leading non-profit organisation dedicated to funding research and providing support for patients affected by blood cancers, including leukemia, lymphoma, and myeloma. Founded in 1949, LLS has made significant strides in advancing treatments and improving patient outcomes, with notable milestones such as the development of targeted therapies and immunotherapies. Operating across major regions in the US, LLS offers a range of core services, including patient education, financial assistance, and advocacy for blood cancer research funding. What sets LLS apart is its commitment to investing in innovative research and its comprehensive support network for patients and families. With a strong market position, LLS has raised billions for research and has played a pivotal role in increasing survival rates for blood cancer patients, making it a vital resource in the fight against these diseases.
DitchCarbon Score
How does LLS (Leukemia & Lymphoma Society)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Membership Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LLS (Leukemia & Lymphoma Society)'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LLS (Leukemia & Lymphoma Society)'s reported carbon emissions
The Leukemia & Lymphoma Society (LLS), headquartered in the US, currently does not have any reported carbon emissions data for the most recent year. As such, there are no specific figures available regarding their total emissions or breakdowns by Scope 1, 2, or 3. Additionally, LLS has not outlined any formal reduction targets or commitments related to carbon emissions. There are no initiatives or pledges documented that would indicate a commitment to reducing their carbon footprint or addressing climate change. In the absence of specific emissions data or reduction initiatives, it is unclear how LLS is addressing climate commitments within the context of their operations.
How Carbon Intensive is LLS (Leukemia & Lymphoma Society)'s Industry?
How Carbon Intensive is LLS (Leukemia & Lymphoma Society)'s Location?
LLS (Leukemia & Lymphoma Society)'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LLS (Leukemia & Lymphoma Society) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.